Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001005477-00-004906
Filing Date
2000-06-28
Accepted
2000-06-28 00:00:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D 0001.txt SC 13D/A 9879
2 LETTER OF SSP 0002.txt EX-99.1 7517
3 LETTER 0003.txt EX-99.2 13365
  Complete submission text file 0001005477-00-004906.txt   33337
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Subject) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44365 | Film No.: 663440
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIDIMAN SAM MONTE CARLO PALACE #7 BLVD DES MOULINS MC 98000 MONACO
Business Address BANK OF NOVA SCOTIA BLDG PO BOX 268 4TH FL GRAND CAYMAN CAYMAN 011377931061
SSP SPECIAL SITUATIONS PARTNERS INC (Filed by) CIK: 0001098815 (see all company filings)